MRK Merck & Co., Inc.
MRK Merck & Co., Inc.
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 2 scans as of 2026-08-17 2 bull converging
POC $82.20 · VWAP $104.77 · +29.8% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
2 watchlists
MRK Price Structure
Loading timeframes…
Peers
Every watchlist MRK belongs to, members best 30-day change first — MRK highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@healthcare
Against street estimates
How MRK's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about MRK from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 14 days ago · Aug 4
- Merck & Co (MRK) M&A announcement Summary | Quartr
- Merck Wins FDA Approvals for Keytruda Combination in Kidney Cancer
- Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
- Merck Acquires Terns Pharma for $5.7 Billion in Cash
- Merck & Co (MRK) M&A announcement Summary | Quartr
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
MRK research tape
29 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.